2BC4 image
Deposition Date 2005-10-18
Release Date 2006-05-23
Last Version Date 2024-10-30
Entry Detail
PDB ID:
2BC4
Keywords:
Title:
Crystal structure of HLA-DM
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
2.27 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HLA class II histocompatibility antigen, DM alpha chain
Chain IDs:A, C
Chain Length:211
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:HLA class II histocompatibility antigen, DM beta chain
Chain IDs:B, D
Chain Length:211
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Ligand Molecules
Primary Citation
Small molecules that enhance the catalytic efficiency of HLA-DM.
J.Immunol. 176 4208 4220 (2006)
PMID: 16547258

Abstact

HLA-DM (DM) plays a critical role in Ag presentation to CD4 T cells by catalyzing the exchange of peptides bound to MHC class II molecules. Large lateral surfaces involved in the DM:HLA-DR (DR) interaction have been defined, but the mechanism of catalysis is not understood. In this study, we describe four small molecules that accelerate DM-catalyzed peptide exchange. Mechanistic studies demonstrate that these small molecules substantially enhance the catalytic efficiency of DM, indicating that they make the transition state of the DM:DR/peptide complex energetically more favorable. These compounds fall into two functional classes: two compounds are active only in the presence of DM, and binding data for one show a direct interaction with DM. The remaining two compounds have partial activity in the absence of DM, suggesting that they may act at the interface between DM and DR/peptide. A hydrophobic ridge in the DMbeta1 domain was implicated in the catalysis of peptide exchange because the activity of three of these enhancers was substantially reduced by point mutations in this area.

Legend

Protein

Chemical

Disease

Primary Citation of related structures